4,6-diphenylthieno(3,4-d)(1,3)dioxol-2-one-5,5-dioxide: activating agent for peptide synthesis; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 735985 |
| SCHEMBL ID | 65330 |
| MeSH ID | M0060315 |
| Synonym |
|---|
| 4,6-diphenylthieno-(3,4-d)-(1,3)-dioxol-2-one-5,5-dioxide |
| BIDD:GT0608 |
| 4,6-diphenylthieno(3,4-d)-1,3-dioxol-2-one 5,5-dioxide |
| AKOS015840542 |
| SR-01000643495-1 |
| 4,6-diphenylthieno[3,4-d]-1,3-dioxol-2-one 5,5-dioxide, 95% |
| MAYBRIDGE4_001784 |
| NCGC00177262-01 |
| HMS1526B02 |
| 5,5-dioxo-4,6-diphenylthieno[3,4-d][1,3]dioxol-2-one |
| 4,6-diphenylthieno[3,4-d]-1,3-dioxol-2-one 5,5-dioxide |
| 54714-11-3 |
| einecs 259-301-2 |
| 4,6-diphenylthieno(3,4-d)(1,3)dioxol-2-one-5,5-dioxide |
| CCG-54397 |
| FT-0617275 |
| SCHEMBL65330 |
| 4,6-diphenylthieno[3,4-d]-1,3-dioxol-2-one5,5-dioxide |
| 4,6-diphenylthieno[3,4-d][1,3]dioxol-2-one 5,5-dioxide |
| AKOS024360137 |
| 4,6-diphenylenethio[3,4-d]-1,3-doxol-2-one 5,5-dioxide |
| 4,6-diphenylthieno[2,4-d]-1,3-dioxol-2-one-5,5-dioxide |
| BRD-K45608262-001-02-1 |
| 4,6-diphenylthieno[3,4-d][1,3]dioxol-2-one5,5-dioxide |
| 4,6-diphenyl-2h,5h-5lambda~6~-thieno[3,4-d][1,3]dioxole-2,5,5-trione |
| DTXSID60970033 |
| CS-0327009 |
| Assay ID | Title | Year | Journal | Article |
|---|---|---|---|---|
| AID540299 | A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis | 2010 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21 | Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. |
| AID588519 | A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities | 2011 | Antiviral research, Sep, Volume: 91, Issue:3 | High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. |
| AID1159607 | Screen for inhibitors of RMI FANCM (MM2) intereaction | 2016 | Journal of biomolecular screening, Jul, Volume: 21, Issue:6 | A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway. |
| AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | 2014 | Journal of biomolecular screening, Jul, Volume: 19, Issue:6 | A High-Throughput Assay to Identify Inhibitors of the Apicoplast DNA Polymerase from Plasmodium falciparum. |
| AID1794808 | Fluorescence-based screening to identify small molecule inhibitors of Plasmodium falciparum apicoplast DNA polymerase (Pf-apPOL). | |||
| [information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||||
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (13.13) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||